---
title: Comparative evaluation of multimarker algorithms for early-stage HCC detection
  in multicenter prospective studies
date: '2025-02-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39897614/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250203170930&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: GAAD (Cobas) demonstrated good clinical performance, similar
  to GALAD (Cobas and μTASWAKO) algorithms, in differentiating HCC and CLD controls,
  across all disease stages, etiologies, and regions; therefore, AFP-L3 may have a
  negligible role in GALAD for HCC ...'
disable_comments: true
---
CONCLUSIONS: GAAD (Cobas) demonstrated good clinical performance, similar to GALAD (Cobas and μTASWAKO) algorithms, in differentiating HCC and CLD controls, across all disease stages, etiologies, and regions; therefore, AFP-L3 may have a negligible role in GALAD for HCC ...